BMW, Peugeot and Vauxhall are among the manufacturers who recalled vehicles in October 2025. BMW is recalling 120,611 BMW 3 ...

Add a beneficial impact on climate change to the long list of benefits being attributed to GLP-1 agonist medicines. An unusual study presented at the European Society of Cardiology (ESC) congress in ...

The full data from AstraZeneca's phase 3 BaxHTN trial of baxdrostat has raised hope of an important new treatment option for people who struggle to control their blood pressure with current therapies.

A new meta-analysis from Mattia Galli, MD, PhD, et al., of 21 trials using eight different GLP1-RAs and with nearly 100,000 patients found "conclusive high-certainty evidence" that, vs. controls, the ...

Stay up to date with the latest Eurovision news, covering everything from artist announcements and song releases to national selections and contest developments. This is your reliable source for ...

In-hospital initiation of dapagliflozin in patients hospitalized for acute heart failure (HF) did not significantly reduce the short-term risk of worsening HF or death, based on findings from the DAPA ...